Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
PPharmarise Holdings Corporation logo
2796TSE Standard

Pharmarise Holdings Corporation

ファーマライズホールディングス Yahoo Finance

Recent & upcoming events

Sep 17
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Aug 27
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
Jun 25
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 25
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Nov 26
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Dec 10
Est.
Earnings 1:00 approx.
Q2 earnings
Add to Google Calendar
2027
Mar 4
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
May 26
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
May 27
Est.
Earnings 2:00 approx.
Q3 earnings
Add to Google Calendar
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Aug 19
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Past events
2026
Sep 17
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar

KPI highlights

FY26
Revenue ¥69.51B YoY +9.5%
Operating income ¥979M margin 1.4%
Net income ¥114M YoY —
EPS ¥10 YoY —
P/E —
ROE 1.7% Equity ratio 20% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/05 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥70.60B +1.6%
Operating income ¥1.01B +3.6%
Net income ¥11M -90.4%
EPS ¥1 -90.1%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY24 Q2
Revenue ¥12.98B¥13.30B¥13.47B¥13.48B¥13.73B¥13.79B
Operating income ¥323M¥542M¥331M¥379M¥153M¥53M
Net income ¥141M¥129M¥127M¥155M¥-95M¥-529M
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2025）

事業法人 56%個人 11.9%未開示 32.1%20212022202320242025
事業法人国内機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

㈱ビックフィールド 26.5%㈱ビックフィールド㈱スズケン 20.3%㈱スズケン大野　小夜子 4.1%大野　小夜子ファーマライズ従業員持株会 3.6%ファーマライズ従業員持株会㈱バイタルネット 3.5%㈱バイタルネット中北薬品㈱ 3.5%中北薬品㈱大野　利美知 3.1%大野　利美知20212022202320242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
㈱ビックフィールド 3,015,000 26.5% Yuho (EDINET)
㈱スズケン 2,309,100 20.3% Yuho (EDINET)
大野 小夜子 460,900 4.1% Yuho (EDINET)
ファーマライズ従業員持株会 413,500 3.6% Yuho (EDINET)
㈱バイタルネット 396,000 3.5% Yuho (EDINET)
中北薬品㈱ 396,000 3.5% Yuho (EDINET)
大野 利美知 355,680 3.1% Yuho (EDINET)
ヒグチ産業㈱ 126,000 1.1% Yuho (EDINET)
日医工㈱ 121,800 1.1% Yuho (EDINET)
平松 仁 119,000 1.1% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

6/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 0.3%
✓ Positive operating cash flow ¥3.28B
✓ ROA improved YoY -1.1% → 0.3%
✓ Operating CF exceeds net income (accrual quality) OCF ¥3.28B / net income ¥114M
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 20.9% → 20.3%
✗ Current ratio improved 1.10× → 0.94×
✓ No dilution (shares outstanding did not increase) 12,060,381 → 12,060,381
✗ Gross margin improved 14.1% → 13.6%
✓ Asset turnover improved 1.99× → 2.13×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 20.3%
Current ratio 0.9×
Years of positive operating CF 10 of last 11 yrs
Payout ratio 102%
Latest fiscal year result Profit (net income ¥114M)

Performance history

Last 10 years
0億円174億円348億円521億円695億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 529546517510523516520545635695
Operating income 4.4211.86.4010.312.515.214.49.162.939.79
Ordinary income 3.2410.95.9010.212.915.214.38.331.367.15
Net income 0.07-0.280.235.774.264.473.33-3.51-3.671.14
Total assets 245243242252247237234295319327
Equity 59.056.256.259.563.367.069.974.469.268.6

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥1¥-3¥3¥61¥46¥48¥35¥-33¥-32¥10
ROE 0.1%-0.5%0.4%10.5%7.3%7.2%5.1%-5.1%-5.3%1.7%
Operating CF 21.013.38.9515.719.57.1325.227.113.132.8
Investing CF -8.71-5.27-5.01-7.34-10.8-2.92-7.03-31.2-44.6-19.8
Financing CF -8.16-8.943.54-7.66-7.28-10.3-10.727.79.39-1.81
FCF 12.38.033.948.388.694.2118.2-4.06-31.513.0

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data